The Japanese stem cell and regenerative medicine oversight system is different than here in the U.S. and in Europe. Japan has had a more permissive approach to overseeing regenerative medicine. While most of the attention has focused on fairly legitimate regenerative biotechs and other sponsors in Japan, there are unproven stem cell clinics there. These […] The post Japanese stem cell clinic oversight: the case of MSC clinic Seijikai Fukuoka appeared first on The Niche .
Japanese stem cell clinic oversight: the case of MSC clinic Seijikai Fukuoka
Professor Paul Knoepfler, Ph.D.
